Essity Aktiebolag (publ)
Sweden · SE0009922156 · reports in SEK · Europe
Four figures
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Revenue growth
- Revenue −4.8% in the year to Dec 31, 2025, on the year before.
- Return on equity
- It earned 15% on its shareholders' equity in the year to Dec 31, 2025.
- Equity and assets
- Equity is 51% of its assets, and operations brought in cash in the year.
- Price and earnings
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in SEK.
SEK 138.5B
revenue
13%
operating margin
SEK 12.7B
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | SEK 131.3B | SEK 147.1B | SEK 145.5B | SEK 138.5B |
| Operating profit | SEK 8.5B | SEK 15.1B | SEK 18.3B | SEK 18.5B |
| Net profit to shareholders | SEK 5.6B | SEK 9.6B | SEK 20.9B | SEK 12.7B |
| Earnings per share | SEK 7.93 | SEK 13.60 | SEK 29.83 | SEK 18.37 |
| Dividend per share | SEK 7.00 | SEK 7.25 | SEK 7.75 | SEK 8.25 |
| Cash from operations | SEK 12.9B | SEK 21.6B | SEK 16.8B | SEK 15.5B |
| Cash | SEK 4.3B | SEK 5.2B | SEK 11.0B | SEK 8.5B |
| Total assets | SEK 210.6B | SEK 203.0B | SEK 185.3B | SEK 167.1B |
| Equity | SEK 76.6B | SEK 79.4B | SEK 88.7B | SEK 86.0B |
What they do
In the company's own words, from the annual report.
Koncernen bedriver huvudsakligen verksamhet inom hygien- och hälsoområdet.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the ratios from the filed figures.